CEO Dr Guna Muppuri points to growth in revenues and assets for the junior stock market company as evidence of a positive trajectory for the business that is part of Muppuri’s Bioprist Group, which is busy building out a bigger footprint in the health and wellness market.

https://jamaica-gleaner.com/article/business/20211231/steady-growth-indies-pharma-despite-pandemic-disruptions 

Leave a Reply

Your email address will not be published. Required fields are marked *